U.S. Markets closed

Durata Therapeutics (DRTX) in Focus: Stock Up 5.64%

Zacks Equity Research

Durata Therapeutics, Inc. (DRTX) was a big mover last session, as the company saw its shares jump nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $13.47 to $16.67 in the past one-month time frame, showed a pick-up yesterday at $14.23.

In the last 30 days, the company witnessed 1 upward estimate revision while 2 estimates were revised downward. Also, the Zacks Consensus Estimate of a loss has widened, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this high can last.

Durata Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN), ANI Pharmaceuticals, Inc. (ANIP) and Aastrom Biosciences, Inc. (ASTM) all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

DURATA THERAPEUTICS INC (DRTX): Free Stock Analysis Report

ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report


AASTROM BIOSCIENCES INC (ASTM): Free Stock Analysis Report

Zacks Investment Research